These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12858131

  • 1. Venlafaxine treatment of obsessive-compulsive disorder: case reports.
    Marazziti D.
    CNS Spectr; 2003 Jun; 8(6):421-2. PubMed ID: 12858131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of obsessive-compulsive disorder with venlafaxine.
    Grossman R, Hollander E.
    Am J Psychiatry; 1996 Apr; 153(4):576-7. PubMed ID: 8599411
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
    Denys D, Kavelaars A, Heijnen CJ, Westenberg H.
    Psychopharmacology (Berl); 2002 Dec; 164(4):432. PubMed ID: 12457275
    [No Abstract] [Full Text] [Related]

  • 11. Effects of venlafaxine treatment for ADHD in a child.
    Pleak RR, Gormly LJ.
    Am J Psychiatry; 1995 Jul; 152(7):1099. PubMed ID: 7793453
    [No Abstract] [Full Text] [Related]

  • 12. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
    Albert U, Aguglia E, Maina G, Bogetto F.
    J Clin Psychiatry; 2002 Nov; 63(11):1004-9. PubMed ID: 12444814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of venlafaxine in other psychiatric disorders.
    Ninan PT.
    Depress Anxiety; 2000 Nov; 12 Suppl 1():90-4. PubMed ID: 11098421
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder: Experience From a Specialty Clinic in India.
    Balachander S, Kodancha PG, Arumugham SS, Sekharan JT, Narayanaswamy JC, Reddy YCJ.
    J Clin Psychopharmacol; 2019 Nov; 39(1):82-85. PubMed ID: 30516575
    [Abstract] [Full Text] [Related]

  • 16. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
    Denys D, van Megen H, Westenberg H.
    J Clin Psychiatry; 2002 Aug; 63(8):700-3. PubMed ID: 12197450
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Venlafaxine in the treatment of anxiety disorders.
    Katzman M.
    Expert Rev Neurother; 2004 May; 4(3):371-81. PubMed ID: 15853535
    [Abstract] [Full Text] [Related]

  • 20. Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.
    Rauch SL, O'Sullivan RL, Jenike MA.
    J Clin Psychopharmacol; 1996 Feb; 16(1):81-4. PubMed ID: 8834427
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.